Group One Trading, L.P. Liminal Bio Sciences Inc. Transaction History

Group One Trading, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.32 - $0.5 $72 - $113	-226 Reduced 69.33%	100 $0
Q3 2022 Nov 09, 2022	SELL	$0.4 - $0.59 $26 - $38	-65 Reduced 16.62%	326 $0
Q1 2022 May 12, 2022	SELL	$0.82 - $1.13 $245 - $338	-300 Reduced 43.42%	391 $0
Q4 2021 Feb 11, 2022	SELL	$0.92 - $2.2 $4,149 - $9,922	-4,510 Reduced 86.71%	691 $1,000
Q3 2021 Nov 12, 2021	BUY	$2.15 - $3.92 $5,314 - $9,690	2,472 Added 90.58%	5,201 $12,000
Q2 2021 Aug 10, 2021	BUY	$3.75 - $5.17 $10,233 - $14,108	2,729 New	2,729 $11,000

234

Ticker LMNL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,042,600
Description
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.